Which organization defines the terms in 21 CFR 58.3 that may trigger GLP data requirements?

Prepare for the CITI Good Laboratory Behavior Test with comprehensive multiple-choice questions, flashcards, and detailed explanations. Ensure your knowledge of laboratory best practices is exam-ready!

Multiple Choice

Which organization defines the terms in 21 CFR 58.3 that may trigger GLP data requirements?

Explanation:
The test is asking who sets the definitions used in 21 CFR 58.3, which are part of the FDA’s GLP regulations. The terms defined there are established by the FDA because 21 CFR 58 is the FDA framework for Good Laboratory Practice. These definitions help determine what kinds of studies and data must meet GLP standards when they are used to support regulatory submissions to the FDA, ensuring consistency and reliability across nonclinical safety data. Other organizations have their own GLP-related frameworks, but they don’t define the terms in 21 CFR 58.3. EPA has separate GLP rules for its regulatory programs, OECD provides international GLP guidelines, and NIH is not the regulator defining these terms in the FDA’s GLP regulations.

The test is asking who sets the definitions used in 21 CFR 58.3, which are part of the FDA’s GLP regulations. The terms defined there are established by the FDA because 21 CFR 58 is the FDA framework for Good Laboratory Practice. These definitions help determine what kinds of studies and data must meet GLP standards when they are used to support regulatory submissions to the FDA, ensuring consistency and reliability across nonclinical safety data.

Other organizations have their own GLP-related frameworks, but they don’t define the terms in 21 CFR 58.3. EPA has separate GLP rules for its regulatory programs, OECD provides international GLP guidelines, and NIH is not the regulator defining these terms in the FDA’s GLP regulations.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy